Posted in | News | Medical Sensor

Metabolomx Receives Grant for Lung Cancer Detection Technology

A Mountain View, CA-based diagnostic company Metabolomx has declared that the National Cancer Institute has provided the company with a small business innovation research (SBIR) grant worth $1.14 million.

The Phase 1/11 fast track SBIR contract will be directed towards the R&D of the sensor array system for the detection of lung cancer. The proprietary Metabolomx lung detection technology can identify the molecular fingerprint of the cancer by using a sampling of metabolites obtained from exhaled breath. The developed system is being studied at the Cleveland Clinic in a lung cancer screening study.

The Chief Executive Officer of Metabolomx, Dr Paul Rhodes stated that active tumors produce tiny molecule metabolites, which can be found in exhaled breath. The cancer detection system developed by Metabolomx is a non-invasive system that can facilitate an early detection of the cancer. Dr Rhodes expressed gratitude for the grant received from the cancer institute stating that it will help in validating the technology for breath analysis for various cancers that include breast cancer, lung cancer and colon cancer.

Metabolomx has discovered the breath test for cancer and owns all worldwide rights for the same. The company has used the expertise of professionals in the field of biological and artificial sensor arrays, product development and neural processing. The technology enables quick, non-invasive, cost effective and early identification of lung and other cancers.

Source: Metabolomx

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Choi, Andy. (2022, July 20). Metabolomx Receives Grant for Lung Cancer Detection Technology. AZoSensors. Retrieved on August 12, 2022 from https://www.azosensors.com/news.aspx?newsID=3464.

  • MLA

    Choi, Andy. "Metabolomx Receives Grant for Lung Cancer Detection Technology". AZoSensors. 12 August 2022. <https://www.azosensors.com/news.aspx?newsID=3464>.

  • Chicago

    Choi, Andy. "Metabolomx Receives Grant for Lung Cancer Detection Technology". AZoSensors. https://www.azosensors.com/news.aspx?newsID=3464. (accessed August 12, 2022).

  • Harvard

    Choi, Andy. 2022. Metabolomx Receives Grant for Lung Cancer Detection Technology. AZoSensors, viewed 12 August 2022, https://www.azosensors.com/news.aspx?newsID=3464.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit